Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 4/20 | 0.36 |
| ▸ | CNR1 | P21554 | 4/20 | 0.36 |
| ▸ | CCR3 | P51677 | 1/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.34 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.33 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.33 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22085783 | 1.00 | AR (0.36) | ARCNR1CCR3NR3C1CACNA1H | |
| SCHEMBL22084636 | 0.90 | LMNA (0.36) | NR3C1MAPT | |
| SCHEMBL22031854 | 0.89 | CYP1A2 (0.38) | ARMAPTP2RX7 | |
| SCHEMBL22031792 | 0.87 | CASR (0.40) | MAPTMCL1 | |
| SCHEMBL22085782 | 0.86 | MAPT (0.37) | CACNA1HMAPTP2RX7DAO | |
| SCHEMBL22906239 | 0.85 | MAPT (0.33) | MAPT | |
| SCHEMBL22084637 | 0.85 | POLB (0.35) | CNR1NR3C1MAPTMCL1DAO | |
| SCHEMBL22906297 | 0.85 | LMNA (0.40) | ITGB1ITGA4ITGB7MAPT | |
| SCHEMBL22906232 | 0.85 | MAPT (0.33) | MAPT | |
| SCHEMBL22906269 | 0.85 | CCR3 (0.33) | ARCNR1CCR3NR3C1CACNA1H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12162840-B2 | Herbicidal compositions | SYNGENTA CROP PROTECTION AG (CH) | 2024-12-10 | — | — | US | claimed |
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-09-28 | — | — | US | claimed |
| US-20220119353-A1 | Herbicidal Compositions | SYNGENTA PARTICIPATIONS AG (CH) | 2022-04-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162840-B2 | Herbicidal compositions | DDT, HPD, PNPO | AR 4726/4885CNR1 3230/4885CCR3 3601/4885 |
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | GMDS, DDT, AADAC | AR 4692/4885CNR1 2737/4885CCR3 4208/4885 |
| US-20220119353-A1 | Herbicidal Compositions | DDT, HPD, PNPO | AR 4726/4885CNR1 3230/4885CCR3 3601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.